Rafarma Pharmaceutical news update



Rafarma Pharmaceuticals Signed a Preliminary Agreement for Radiopharmaceutical Production Center


Rapharma and Kelun Lifesciences have entered into a preliminary agreement

Rafarma Pharmaceuticals plans to open an enterprise in Hong Kong


Rafarma Pharmaceuticals continues to develop projects on isotopes in Kazakhstan


Rafarma Pharmaceuticals is negotiating with an investment fund


Rafarma Pharmaceuticals met with the Kazakhstan chief specialist in nuclear medicine


Rafarma Pharmaceuticals arranged a meeting with CERES F&D Inc.


Rafarma Pharmaceuticals negotiated with the Ministry of Kazakhstan


Rafarma Pharmaceuticals is preparing to participate in a conference dedicated to modern neuroscience


Rafarma Pharmaceuticals registered NOYA THERAPEUTICS LTD company in Israel


Letter to the Shareholders from President Raivo Unt


Rafarma Pharmaceuticals plans to build a production unit of pharmacopeial substances in Yeruham


Rafarma Pharmaceuticals has entered into negotiations with Israel Ariel University

Rafarma Pharmaceuticals appoints pharmaceutical industry leader Unt Raivo as new CEO

Slavich Noya Technology announces H1 2022 results


Rafarma Pharmaceuticals is continuing to develop smart packaging for a wide range of medicines

Rafarma Pharmaceuticals has signed an agreement with Istem Medikal


Rafarma Pharmaceuticals strengthens its position in Central Asia


Rafarma Pharmaceuticals develops new liposome-based medicine for targeted therapy